
Significant metabolic changes are seen in the first 90 days of use of antipsychotic medications, say researchers who recommend closer monitoring at the start.
An analysis of the risk of diabetes associated with use of second-generation antipsychotics found rapid increase in HbA1c and weight happen in the first 90 days after initiation with slower rises up to two years.
Data from anonymised NHS GP health records from nearly 97,000 adults in England with severe mental illness who started taking olanzapine, quetiapine, risperidone or aripiprazole between 2000 and 2023 showed that in this early period, HbA1c rose around 14 times faster and weight around nine times faster, than before antipsychotic treatment began.
Reporting the findings in The Lancet Psychiatry, the researchers also noted that changes in blood sugar and weight did not always occur together, suggesting that weight alone should not be used to monitor metabolic risk.
Women and people prescribed olanzapine had the steepest short-term metabolic changes, they added.
In people who had started taking olanzapine, HbA1c rose around 50 times faster and weight around 10 times faster in the first 90 days.
The study also found that individuals prescribed quetiapine had marked weight gain with minimal HbA1c change.
Those with pre-diabetes before treatment were more at risk with 19% developing type 2 diabetes within two years, compared with 3% starting with normal blood sugar levels.
Baseline and 12-week assessment should include both HbA1c and weight, with closer monitoring and early preventive support for people starting higher-risk antipsychotics, particularly olanzapine, and for those with prediabetes or other cardiometabolic risk factors, they concluded.
It is the first large study to look at trajectories of weight and HbA1c before and after initiation of antipsychotic medications in routine practice.
Researcher Dr Juan Carlos Bazo-Alvarez, a senior research fellow at University College London Epidemiology said: ‘Antipsychotic medicines are valuable treatments that help many people with serious mental illnesses.
‘However, our study shows that the first 90 days after starting treatment are a key period when changes linked to diabetes and weight gain can begin.
‘With this information in mind, healthcare professionals should check both weight and blood sugar before treatment starts and again during the first few months afterwards.’
He noted that people with severe mental illness typically dye around 10-20 years earlier than average primarily driven by greater incidence of cardiovascular and metabolic disease.
Dr Bazo-Alvarez added: ‘Our findings may also help clinicians to pay particular attention to certain groups who may be more at risk. ‘This could mean that patients are able to receive the benefits of antipsychotic medicines while reducing their risk of developing conditions such as type 2 diabetes.’
Continue with clinical updates and expert-led education before the year ends in person at Pulse LIVE in Belfast, Liverpool, or virtually. Register today to save your free spot and connect with peers. Check out what’s on the calendar and join us at the next one!